Christopher Barys

Christopher R.
Barys currently works at Radiaction Ltd., as Chief Executive Officer & Non-Executive Director from 2023 and Urologix, Inc., as Independent Director from 2010.
Mr. Barys also formerly worked at On Target Laboratories, Inc., as President, Chief Executive Officer & Director from 2019 to 2023, Cordis Corp., as Director-Global Market Development in 2005, CloSys Corp., as Director, Compumedics Ltd., as Non-Executive Director from 2025 to 2026, Johnson & Johnson, as Principal, I-Flow Corp., as Vice President & General Manager, Boston Scientific Corp., as Principal, Edwards Lifesciences Corp., as Vice President-Sales & Marketing, Kimberly-Clark Health Care, Inc., as General Manager, FlowCardia, Inc., as Chief Operating Officer in 2010, Sonablate Corp., as Chief Operating Officer, and Covidien Unlimited Co., as VP & General Manager-Interventional Lung Solutions.
Mr. Barys received his undergraduate degree from Northern Illinois University.